• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

iVue Normative Database receives FDA clearance

Article

Optovue has received FDA 510(k) clearance of the Normative Database for its iVue SD-OCT system. The Normative Database analyzes information to be used as clinical reference in the diagnosis and management of ocular health and disease.

Fremont, CA-Optovue Inc. has received FDA 510(k) clearance of the Normative Database for its iVue SD-OCT system. The Normative Database processes information to be used as a clinical reference to aid in the diagnosis and management of ocular health and disease.

The iVue Normative Database provides quantitative comparisons of the retina, retinal nerve fiber layer, ganglion cell complex, and optic disc measurements to aid the practitioner in evaluating various ocular pathologies. After scans are captured, the normative comparison analysis adjusts for the patient’s age, optic disc size (for optic nerve head scans only), and scan signal strength. Symmetry and change analyses combined with normative comparisons support patient evaluation and management.

The Normative Database is included with any iVue SD-OCT system purchase. A new software update will be provided free-of-charge to all current iVue owners of record.

The update is expected to be made available in early March.

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.